These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 9113094)
1. Relationship between expression level of P-glycoprotein and daunorubicin transport in LLC-PK1 cells transfected with human MDR1 gene. Tanaka K; Hirai M; Tanigawara Y; Ueda K; Takano M; Hori R; Inui K Biochem Pharmacol; 1997 Mar; 53(5):741-6. PubMed ID: 9113094 [TBL] [Abstract][Full Text] [Related]
2. Interaction of docetaxel ("Taxotere") with human P-glycoprotein. Shirakawa K; Takara K; Tanigawara Y; Aoyama N; Kasuga M; Komada F; Sakaeda T; Okumura K Jpn J Cancer Res; 1999 Dec; 90(12):1380-6. PubMed ID: 10665657 [TBL] [Abstract][Full Text] [Related]
3. The novel anticancer drug KRN5500 interacts with, but is hardly transported by, human P-glycoprotein. Takara K; Tanigawara Y; Komada F; Nishiguchi K; Sakaeda T; Okumura K Jpn J Cancer Res; 2000 Feb; 91(2):248-54. PubMed ID: 10761713 [TBL] [Abstract][Full Text] [Related]
4. Effects of alpha-adrenoceptor antagonist doxazosin on MDR1-mediated multidrug resistance and transcellular transport. Takara K; Sakaeda T; Kakumoto M; Tanigawara Y; Kobayashi H; Okumura K; Ohnishi N; Yokoyama T Oncol Res; 2009; 17(11-12):527-33. PubMed ID: 19806783 [TBL] [Abstract][Full Text] [Related]
5. Cellular pharmacokinetic aspects of reversal effect of itraconazole on P-glycoprotein-mediated resistance of anticancer drugs. Takara K; Tanigawara Y; Komada F; Nishiguchi K; Sakaeda T; Okumura K Biol Pharm Bull; 1999 Dec; 22(12):1355-9. PubMed ID: 10746169 [TBL] [Abstract][Full Text] [Related]
6. Transport of quinolone antibacterial drugs by human P-glycoprotein expressed in a kidney epithelial cell line, LLC-PK1. Ito T; Yano I; Tanaka K; Inui KI J Pharmacol Exp Ther; 1997 Aug; 282(2):955-60. PubMed ID: 9262363 [TBL] [Abstract][Full Text] [Related]
7. Effects of Kaempferia parviflora extracts and their flavone constituents on P-glycoprotein function. Patanasethanont D; Nagai J; Yumoto R; Murakami T; Sutthanut K; Sripanidkulchai BO; Yenjai C; Takano M J Pharm Sci; 2007 Jan; 96(1):223-33. PubMed ID: 17031860 [TBL] [Abstract][Full Text] [Related]
8. Effects of carvedilol on MDR1-mediated multidrug resistance: comparison with verapamil. Kakumoto M; Sakaeda T; Takara K; Nakamura T; Kita T; Yagami T; Kobayashi H; Okamura N; Okumura K Cancer Sci; 2003 Jan; 94(1):81-6. PubMed ID: 12708479 [TBL] [Abstract][Full Text] [Related]
9. Effect of cyclosporin analogues and FK506 on transcellular transport of daunorubicin and vinblastine via P-glycoprotein. Tanaka K; Hirai M; Tanigawara Y; Yasuhara M; Hori R; Ueda K; Inui K Pharm Res; 1996 Jul; 13(7):1073-7. PubMed ID: 8842048 [TBL] [Abstract][Full Text] [Related]
10. Kinetics of doxorubicin handling in the LLC-PK1 kidney epithelial cell line is mediated by both vesicle formation and P-glycoprotein drug transport. Crivellato E; Candussio L; Rosati AM; Decorti G; Klugmann FB; Mallardi F Histochem J; 1999 Oct; 31(10):635-43. PubMed ID: 10576412 [TBL] [Abstract][Full Text] [Related]
11. Interactions of attention-deficit/hyperactivity disorder therapeutic agents with the efflux transporter P-glycoprotein. Zhu HJ; Wang JS; Donovan JL; Jiang Y; Gibson BB; DeVane CL; Markowitz JS Eur J Pharmacol; 2008 Jan; 578(2-3):148-58. PubMed ID: 17963743 [TBL] [Abstract][Full Text] [Related]
12. Differences in the expression of endogenous efflux transporters in MDR1-transfected versus wildtype cell lines affect P-glycoprotein mediated drug transport. Kuteykin-Teplyakov K; Luna-Tortós C; Ambroziak K; Löscher W Br J Pharmacol; 2010 Jul; 160(6):1453-63. PubMed ID: 20590635 [TBL] [Abstract][Full Text] [Related]
13. P-glycoprotein mediates efflux transport of darunavir in human intestinal Caco-2 and ABCB1 gene-transfected renal LLC-PK1 cell lines. Fujimoto H; Higuchi M; Watanabe H; Koh Y; Ghosh AK; Mitsuya H; Tanoue N; Hamada A; Saito H Biol Pharm Bull; 2009 Sep; 32(9):1588-93. PubMed ID: 19721237 [TBL] [Abstract][Full Text] [Related]
14. Directional transcellular transport of bisoprolol in P-glycoprotein-expressed LLC-GA5-COL150 cells, but not in renal epithelial LLC-PK1 Cells. Tahara K; Kagawa Y; Takaai M; Taguchi M; Hashimoto Y Drug Metab Pharmacokinet; 2008; 23(5):340-6. PubMed ID: 18974611 [TBL] [Abstract][Full Text] [Related]
15. Interaction of digoxin with antihypertensive drugs via MDR1. Takara K; Kakumoto M; Tanigawara Y; Funakoshi J; Sakaeda T; Okumura K Life Sci; 2002 Feb; 70(13):1491-500. PubMed ID: 11895100 [TBL] [Abstract][Full Text] [Related]
16. Effect of PCB-126 on intracellular accumulation and transepithelial transport of vinblastine in LLC-PK1 and its transformant cells expressing human P-glycoprotein. Sasawatari S; Toki M; Horie T; Nakano Y; Ikeda T; Ueda K; Fujise H J Vet Med Sci; 2004 Sep; 66(9):1079-85. PubMed ID: 15472471 [TBL] [Abstract][Full Text] [Related]
17. Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines. van der Sandt IC; Blom-Roosemalen MC; de Boer AG; Breimer DD Eur J Pharm Sci; 2000 Sep; 11(3):207-14. PubMed ID: 11042226 [TBL] [Abstract][Full Text] [Related]
18. Cepharanthin, a multidrug resistant modifier, is a substrate for P-glycoprotein. Hirai M; Tanaka K; Shimizu T; Tanigawara Y; Yasuhara M; Hori R; Kakehi Y; Yoshida O; Ueda K; Komano T J Pharmacol Exp Ther; 1995 Oct; 275(1):73-8. PubMed ID: 7562598 [TBL] [Abstract][Full Text] [Related]
19. In Vitro P-Glycoprotein-Mediated Transport of Tadalafil: A Comparison with Sildenafil. Higashi H; Watanabe N; Tamura R; Taguchi M Biol Pharm Bull; 2017; 40(8):1314-1319. PubMed ID: 28769012 [TBL] [Abstract][Full Text] [Related]
20. Human P-glycoprotein transports cyclosporin A and FK506. Saeki T; Ueda K; Tanigawara Y; Hori R; Komano T J Biol Chem; 1993 Mar; 268(9):6077-80. PubMed ID: 7681059 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]